Abstract: The present disclosure provides a scalable step-wise process for purification of diphtheria toxoid that is faster, and provides reduced process variability in toxoid retention.
CLIAMS:1. A scalable two-step method for purification of immunogenic diphtheria toxoid, said method comprising the steps of:
a. obtaining an immunogenic diphtheria toxoid containing material prepared from fermentation of Corynebacterium diphtheriae in deferrated papain digest medium;
b. carrying out a first step of separation of diphtheria toxoid using a tangential flow filtration setup having membrane pore size in the range of 100-500kDa to obtain a filtrate;
c. carrying out a second step of separation of filtrate from step b) using a tangential flow filtration setup having membrane pore size in the range of 10-30kDa to obtain a retentate comprising of purified immunogenic diphtheria toxoid,
wherein the purity of diphtheria toxoid is in the range of 1800-2200Lf/mg pN, and wherein the percentage recovery of said purified diphtheria toxoid is in the range of 85-95%.
2. The method as claimed in claim 1, wherein percentage recovery of diphtheria toxoid in said filtrate is in the range of 85-95%.
3. The method as claimed in claim 1, wherein percentage recovery of diphtheria toxoid in said retentate is in the range of 85-95%.
4. A scalable one-step method for purification of immunogenic diphtheria toxoid, said method comprising the steps of:
a. obtaining an immunogenic diphtheria toxoid containing material prepared from semi-synthetic medium;
b. carrying out a separation of diphtheria toxoid using a tangential flow filtration setup having membrane pore size in the range of 10-30kDa to obtain a retentate comprising of purified immunogenic diphtheria toxoid,
wherein the purity of diphtheria toxoid is in the range of 1700-2600Lf/mg pN, and wherein the percentage recovery of said purified diphtheria toxoid is in the range of 85-90%.
5. The method as claimed in any of the claims 1-4, wherein said purified immunogenic diphtheria toxoid is optionally further filter sterilized with a 0.2µm filter.
,TagSPECI:As Attached
| # | Name | Date |
|---|---|---|
| 1 | 3601-CHE-2015-FORM 4(ii) [25-11-2021(online)].pdf | 2021-11-25 |
| 1 | PD016488IN-SC FORM 5.pdf | 2015-07-17 |
| 2 | PD016488IN-SC FORM 3.pdf | 2015-07-17 |
| 2 | 3601-CHE-2015-FER.pdf | 2021-10-17 |
| 3 | PD016488IN-NP SPEC FOR E-FILING.pdf | 2015-07-17 |
| 3 | 3601-CHE-2015-FORM-26 [26-07-2021(online)].pdf | 2021-07-26 |
| 4 | 3601-CHE-2015-Representation,including the statement and evidence [26-07-2021(online)].pdf | 2021-07-26 |
| 4 | Indian Immunologicals Limited.pdf | 2015-07-17 |
| 5 | 3601-CHE-2015-FORM 18 [12-07-2019(online)].pdf | 2019-07-12 |
| 5 | 3601-CHE-2015 FORM-1 05-08-2015.pdf | 2015-08-05 |
| 6 | Form 3 [17-10-2016(online)].pdf | 2016-10-17 |
| 6 | 3601-CHE-2015 CORRESPONDENCE OTHERS 05-08-2015.pdf | 2015-08-05 |
| 7 | REQUEST FOR CERTIFIED COPY [14-07-2016(online)].pdf | 2016-07-14 |
| 8 | Form 3 [17-10-2016(online)].pdf | 2016-10-17 |
| 8 | 3601-CHE-2015 CORRESPONDENCE OTHERS 05-08-2015.pdf | 2015-08-05 |
| 9 | 3601-CHE-2015-FORM 18 [12-07-2019(online)].pdf | 2019-07-12 |
| 9 | 3601-CHE-2015 FORM-1 05-08-2015.pdf | 2015-08-05 |
| 10 | 3601-CHE-2015-Representation,including the statement and evidence [26-07-2021(online)].pdf | 2021-07-26 |
| 10 | Indian Immunologicals Limited.pdf | 2015-07-17 |
| 11 | 3601-CHE-2015-FORM-26 [26-07-2021(online)].pdf | 2021-07-26 |
| 11 | PD016488IN-NP SPEC FOR E-FILING.pdf | 2015-07-17 |
| 12 | PD016488IN-SC FORM 3.pdf | 2015-07-17 |
| 12 | 3601-CHE-2015-FER.pdf | 2021-10-17 |
| 13 | PD016488IN-SC FORM 5.pdf | 2015-07-17 |
| 13 | 3601-CHE-2015-FORM 4(ii) [25-11-2021(online)].pdf | 2021-11-25 |
| 1 | SearchreportE_18-05-2021.pdf |